EGFL7 enhances surface expression of integrin α5β1 to promote angiogenesis in malignant brain tumors

Abstract Glioblastoma (GBM) is a typically lethal type of brain tumor with a median survival of 15 months postdiagnosis. This negative prognosis prompted the exploration of alternative treatment options. In particular, the reliance of GBM on angiogenesis triggered the development of anti‐VEGF (vascu...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Nevenka Dudvarski Stanković, Frank Bicker, Stefanie Keller, David TW Jones, Patrick N Harter, Arne Kienzle, Clarissa Gillmann, Philipp Arnold, Anna Golebiewska, Olivier Keunen, Alf Giese, Andreas von Deimling, Tobias Bäuerle, Simone P Niclou, Michel Mittelbronn, Weilan Ye, Stefan M Pfister, Mirko HH Schmidt
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Springer Nature 2018-08-01
Serie:	EMBO Molecular Medicine
Soggetti:	angiogenesis EGFL7 endothelial cell glioblastoma integrin
Accesso online:	https://doi.org/10.15252/emmm.201708420
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!